Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

被引：0
作者：
Wilbert S. Aronow
机构：
[1] Hebrew Hospital Home,The Department of Geriatrics and Adult Development
[2] Mount Sinai School of Medicine,undefined
来源：
Drugs & Aging | 1999年 / 15卷
关键词：
Aspirin; Clopidogrel; Ticlopidine; Transient Ischaemic Attack; Peripheral Occlusive Arterial Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Antiplatelet drugs have been demonstrated to reduce the incidence of myocardial infarction (MI), stroke or vascular death in patients with vascular disease. There are no data suggesting that antiplatelet therapy acts differently in older people than in younger people and recommendations based on randomised clinical trials are probably generalisable to older people.
引用
收藏
页码：91 / 101
页数：10
相关论文
共 127 条
  • [31] Archibald DG(1997)CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke Lancet 349 1641-9
  • [32] Theroux P(1993)Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke Lancet 342 1255-62
  • [33] Ouimet H(1994)Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1449-57
  • [34] McCans J(1996)Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation III randomised clinical trial Lancet 348 633-8
  • [35] Wallentin L t(1993)Acomparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 524-9
  • [36] Borzak S(1985)Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease Lancet I 415-9
  • [37] Cannon CP(1993)Dose-dependent effect of aspirin on carotid atherosclerosis Circulation 87 1873-9
  • [38] Kraft PL(1994)Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis in pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients BMJ 308 235-46
  • [39] Juul-Moller S(1996)A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis N Engl J Med 334 677-81
  • [40] Edvardsson N(1989)Final report on the aspirin component of the ongoing physicians health study N Engl J Med 321 129-35
12345678910